Specialized pro-resolving lipid mediators: A future for conventional endodontics-A review

---

Review Article

Author Details : Saravanan Merularini*, Madhuram Krishnamurthy, Ashok Leburu, Praveen Nehrudas, Selvendran K Elangovan, Naveen Kumar Venugopal

Volume : 7, Issue : 3, Year : 2022

Article Page : 105-108

https://doi.org/10.18231/j.ijce.2022.023

Suggest article by email

Get Permission

---

Abstract

Human dental pulp is a highly dynamic tissue that plays major roles in the defense against pathogens and during tissue injury. However, the efficiency of these mechanisms during dental pulp inflammation (pulpitis) varies due to anatomical and physiological restrictions. Uncontrolled progressive unresolved inflammation can lead to pulp tissue necrosis and subsequent apical periodontitis or it can develop into chronic inflammation and become a silent killer causing bone destruction. Considering the cause & effect model, the decision to perform pulp extirpation and endodontic treatment is justifiable only by the lack of therapeutic tools that limit the immune/inflammatory process. The resolution of acute inflammation is necessary to avoid the development of chronic inflammation and to promote repair or regeneration. This active process is orchestrated by Specialized Pro-resolving lipid Mediators (SPMs), which include several families of distinct local mediators (lipoxins, resolvins, protectins and Maresins). These immunoresolvents are distinct from immunosuppressive molecules as they not only dampen inflammation but also promote host defense. Experimental application of SPMs has shown promising result in wide range of inflammatory diseases. This article illustrates about the potential use of SPMs in dentistry
 

Keywords: SPMs, Resolution of inflammation, Pulpitis, Apical periodontitis, Revascularisation

How to cite : Merularini S, Krishnamurthy M, Leburu A, Nehrudas P, Elangovan S K, Venugopal N K, Specialized pro-resolving lipid mediators: A future for conventional endodontics-A review. IP Indian J Conserv Endod 2022;7(3):105-108

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.